Live Breaking News & Updates on Mackenzie Partners

Stay updated with breaking news from Mackenzie partners. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Glass Lewis recommends Hess shareholders vote for proposed merger with Chevron

Hess Corporation has announced that independent proxy voting and corporate governance advisory firm Glass Lewis has recommended that Hess shareholders vote FOR the proposed merger with Chevron. ....

John Hess , Mackenzie Partners Inc , Hess Corporation , Glass Lewis , Mackenzie Partners ,

Glass Lewis Recommends Hess Shareholders Vote For Proposed Merger With Chevron

Hess Corporation today announced that independent proxy voting and corporate governance advisory firm Glass, Lewis & Co. has recommended that Hess shareholders vote FOR the proposed merger with. ....

John Hess , Hess Corporation , Securities Exchange , Lewis Co , Exchange Commission , Party Transactions , Mackenzie Partners Inc , Glass Lewis , Mackenzie Partners , Securities Act , Securities Exchange Act , Stabroek Block , Annual Report , Hes Annual Report , Executive Officers , Current Report , Regulations K , Chess Board , Its Reasons , Officer Indemnification , Merger Agreement , Merger Consideration , Hess Equity Awards , Hes Directors , Advisory Vote , Merger Related Compensation ,

Mason Capital Announces Tender Offer for Any and All of (i) the Outstanding American Depositary Shares (the "ADSs"), each representing 4,000 Ordinary Shares, Nominal Value 0.01 DKK of Forward Pharma A/S (the "Ordinary Shares") for a Purchase Price of $437.00 per ADS and (ii) the Outstanding Ordinary Shares for a Purchase Price of 0.76 DKK per Ordinary Share

NEW YORK, May 14, 2024 /PRNewswire/ — Mason Capital Management LLC, a Delaware limited liability company (“Mason Capital”), announced today that it has commenced a tender offer (the “Tender Offer”) for any and all the outstanding ADSs and Ordinary Shares in Forward Pharma A/S (the “Company”) for a purchase price of $437.00 per ADS or […] ....

United States , Mike Martino , Ken Garschina , Mason Capital Management , Ordinary Shares , Forward Pharma , Tender Offer , Eastern Standard Time , Share Transfer Note , Tender Offer Materials , Mackenzie Partners , Mason Capital , Expiration Date , Capital Management ,

Genco Shipping & Trading Limited Highlights ISS Recommendation To Vote "FOR" Each Of Genco'S Director Nominees

Genco Shipping & Trading Limited Highlights ISS Recommendation To Vote "FOR" Each Of Genco'S Director Nominees
menafn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from menafn.com Daily Mail and Mail on Sunday newspapers.

Wilkinson Brimmer Katcher , Peter Allen , Arthurl Regan , Johnc Wobensmith , George Economou , Joele Frank , Jamesg Dolphin , Joseph Adamo , Kathleenc Haines , Basilg Mavroleon , Robert Pons , Kariny Orsel , Jesper Christensen , Genco Shipping Trading , Institutional Shareholder Services , Exchange Commission , Genco Shipping Trading Limited , Company Annual , Compelling Case , Trading Limited , Annual Meeting , Genco Board , Comprehensive Value Strategy , Mackenzie Partners , Genco Shipping , Private Securities Litigation Reform Act ,

Future Pak Increases Bid for Vanda Pharmaceuticals to Include CVRs in Addition to $7.25 to $7.75 Per Share in Cash

Future Pak Increases Bid for Vanda Pharmaceuticals to Include CVRs in Addition to $7.25 to $7.75 Per Share in Cash
lelezard.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from lelezard.com Daily Mail and Mail on Sunday newspapers.

United States , Vanda Pharmaceuticals , Moelis Company , Mackenzie Partners Inc , Pak Increases Bid , Contingent Value Rights , Future Pak , Tina Guilder , Prescription Drug User Fee Act , Revised Proposal , Colbeck Capital , Mackenzie Partners ,